Introduction: Who Should Undergo Diagnostics and When

Stage IV breast cancer, also called metastatic or advanced breast cancer, describes cancer that has moved beyond the breast and nearby areas to distant parts of the body. This spreading process is known as metastasis. Not everyone with breast cancer will develop stage IV disease, but knowing when to seek diagnostic testing is important for both people newly diagnosed and those who have been treated before.^[1][2]

Some people receive a stage IV diagnosis right from the start. This is called de novo metastatic breast cancer, meaning the cancer was already widespread when first discovered. About 6% of women and around 10% of men in the United States are diagnosed with stage IV breast cancer as their initial diagnosis.^[6][10]

Most commonly, however, stage IV breast cancer appears as a recurrence. This happens when someone has been treated for earlier-stage breast cancer, but some cancer cells were left behind. These cells can remain hidden or inactive for months or even years before they start growing again and spread to other organs. When this occurs, the original cancer in the breast is called the primary cancer, and the new growth in another part of the body is still considered breast cancer — not cancer of the organ where it has spread.^[5][6]

You should seek diagnostic evaluation if you have been previously treated for breast cancer and begin experiencing new or unusual symptoms. These may include persistent bone pain, unexplained weight loss, constant fatigue, trouble breathing, frequent headaches, or changes in vision. Sometimes symptoms are specific to where the cancer has spread. For example, if cancer moves to the liver, you might notice yellowing of the skin or eyes, stomach pain, or loss of appetite. If it spreads to the bones, you could feel pain in your back, neck, or joints, or experience fractures more easily than before.^[5][6][20]

Even if you have no symptoms, regular follow-up appointments after breast cancer treatment are important. Your doctor may recommend periodic tests to monitor your health and catch any signs of recurrence early. In some cases, high enzyme levels on routine blood tests or changes detected during imaging can reveal metastatic cancer before symptoms appear.^[5]

Diagnostic Methods to Identify and Confirm Stage IV Breast Cancer

When doctors suspect that breast cancer has spread to other parts of the body, they use a variety of diagnostic tests to confirm the diagnosis and determine where the cancer has traveled. These tests help distinguish stage IV breast cancer from other medical conditions and guide treatment decisions. The diagnostic process typically involves imaging studies, laboratory tests, and sometimes tissue biopsies.^[3][6]

Imaging Tests

Imaging is one of the most important tools for detecting metastatic breast cancer. These tests create detailed pictures of the inside of your body, allowing doctors to see if cancer has spread to bones, organs, or other tissues. Different types of imaging are used depending on which areas need to be examined.

CT scans (computed tomography scans) are commonly used to look for cancer in the chest, abdomen, and pelvis. A CT scan uses X-rays and a computer to create cross-sectional images of your body. It can reveal tumors in the lungs, liver, and other organs. You may be asked to drink a contrast dye or receive it through an intravenous line to make certain areas show up more clearly on the images.^[3]

MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of X-rays. MRI is particularly useful for examining the brain and spinal cord, as it provides very detailed images of soft tissues. If your doctor suspects that breast cancer has spread to your brain, an MRI will likely be ordered. This test does not involve radiation, but it can be noisy and requires you to lie still inside a tube-like machine for 30 to 60 minutes.^[3]

Bone scans (also called nuclear scans or radionuclide scanning) are used to detect cancer that has spread to the bones. For this test, a small amount of radioactive substance is injected into a vein. This substance travels through your bloodstream and collects in areas of bone where cancer may be present. A special camera then takes pictures of your skeleton. Areas with cancer or other bone problems will show up as darker spots on the images. Bone scans are very sensitive and can detect bone metastases before they cause symptoms or show up on regular X-rays.^[3]

PET scans (positron emission tomography) can show how tissues and organs are functioning, not just what they look like. A small amount of radioactive sugar is injected into your bloodstream. Cancer cells, which use more sugar than normal cells, absorb more of this substance and show up as bright spots on the scan. PET scans are often combined with CT scans (called PET-CT) to provide both functional and structural information. This test can help doctors see if cancer has spread to multiple areas of the body at once.^[3]

Ultrasound uses sound waves to create images of organs and tissues. It may be used to examine the liver or other abdominal organs if doctors suspect cancer has spread there. Ultrasound is painless, does not use radiation, and can often be done quickly in a doctor’s office or imaging center.^[3]

Laboratory Tests

Blood tests play an important role in diagnosing and monitoring stage IV breast cancer. While blood tests alone cannot confirm that cancer has spread, they provide valuable information about how your organs are functioning and whether there are signs that cancer may be affecting them.^[6]

Doctors may order tests to check your liver function. If cancer has spread to the liver, certain enzymes and proteins in your blood may be higher than normal. Elevated liver enzymes can be an early clue that prompts further imaging studies to look for liver metastases.^[5]

Complete blood counts (CBC) measure the levels of different types of blood cells. If cancer has spread to the bone marrow, it can affect your body’s ability to produce red blood cells, white blood cells, and platelets. This can lead to anemia, increased risk of infection, or problems with blood clotting.^[6]

Blood tests may also check levels of calcium and other minerals. When breast cancer spreads to the bones, it can cause calcium to be released into the bloodstream, leading to high calcium levels. This condition, called hypercalcemia, can cause symptoms like nausea, confusion, and fatigue.^[6]

Biopsies

A biopsy involves taking a small sample of tissue from a suspicious area so that it can be examined under a microscope. This is the only way to definitively confirm that cancer has spread to a new location. Not everyone with suspected metastatic breast cancer will need a biopsy, but it may be recommended in certain situations.^[6]

If imaging tests show a mass or abnormal area in a distant organ, your doctor may perform a biopsy to confirm it is breast cancer and not a different type of cancer or a benign condition. The biopsy also allows doctors to test the cancer cells for important characteristics, such as hormone receptor status (whether the cancer is sensitive to estrogen or progesterone) and HER2 status (whether the cancer has high levels of a protein called HER2). These features can change over time, so even if your original breast tumor was tested years ago, doctors may want to test the metastatic tumor again. This information helps guide treatment choices.^[6][7]

Biopsies can be done in different ways depending on where the suspected cancer is located. A needle biopsy uses a thin needle to remove a small piece of tissue. For tumors in the liver, lungs, or other organs, this may be done with the help of imaging guidance to ensure the needle reaches the right spot. In some cases, a surgical biopsy may be needed, which involves making a small incision to remove tissue.^[6]

Additional Tests

Sometimes doctors perform other specialized tests to look for specific complications of metastatic breast cancer. For example, if you have symptoms suggesting that cancer has spread to the lining around your lungs (called the pleura), a procedure called thoracentesis may be done. This involves inserting a needle between the ribs to remove fluid from around the lungs. The fluid is then tested for cancer cells.^[6]

Similarly, if cancer is suspected in the fluid around the abdomen, a procedure called paracentesis can remove and test abdominal fluid. These procedures not only help with diagnosis but can also relieve symptoms like difficulty breathing or abdominal swelling.^[6]

Diagnostics for Clinical Trial Qualification

Many patients with stage IV breast cancer consider participating in clinical trials. These research studies test new treatments or new ways of using existing treatments. Clinical trials can offer access to cutting-edge therapies that are not yet widely available. However, to be eligible for a trial, patients must meet specific criteria, and diagnostic tests play a key role in determining whether someone qualifies.^[8][10]

Before enrolling in a clinical trial, you will undergo a thorough evaluation to confirm your diagnosis and assess your overall health. Researchers need detailed information about your cancer, including its stage, where it has spread, and its molecular characteristics. They also need to know how well your organs are functioning and whether you have any other medical conditions that might affect your participation.^[10]

Confirming Stage and Extent of Disease

Clinical trials for metastatic breast cancer typically require imaging studies to confirm that the cancer is indeed stage IV and to document which organs are affected. You may need a combination of CT scans, PET scans, bone scans, or MRI scans. These baseline images are used not only to determine eligibility but also to measure the cancer’s response to treatment during the trial.^[8]

Some trials are designed for patients whose cancer has spread to specific organs. For example, a trial might focus on treating brain metastases or bone metastases. In these cases, imaging must clearly show cancer in the target organ. Conversely, some trials may exclude patients whose cancer has spread to certain areas, such as the brain, because those patients require different management strategies.^[8]

Tumor Characteristics and Biomarker Testing

Many clinical trials are designed to test treatments that target specific features of breast cancer. To determine if you are a good candidate, doctors will need detailed information about your tumor’s biology. This usually requires a biopsy of the metastatic tumor, not just relying on tests done on your original breast tumor.^[7]

Key tests include:

• Hormone receptor testing to see if the cancer cells have receptors for estrogen or progesterone. Hormone receptor-positive cancers may respond to hormone therapy.
• HER2 testing to determine if the cancer has high levels of the HER2 protein. HER2-positive cancers can be treated with targeted drugs like trastuzumab.
• Genetic mutation testing to look for changes in genes such as BRCA1, BRCA2, or PIK3CA. Some clinical trials test drugs that target specific genetic mutations.

Some trials require that your cancer has a particular biomarker or genetic change. For example, a trial might only enroll patients with HER2-positive disease or those with a BRCA mutation. Other trials may focus on patients whose cancer lacks certain features, such as triple-negative breast cancer (which does not have hormone receptors or HER2).^[7][11]

Organ Function Tests

Clinical trials have strict safety requirements. Before you can join, doctors need to make sure your body can handle the experimental treatment. This usually means testing how well your major organs are working.

Blood tests are used to check kidney function (by measuring substances like creatinine) and liver function (by measuring enzymes and bilirubin). If your kidneys or liver are not working well, you may not be able to process certain drugs safely, which could disqualify you from some trials.^[8]

Your bone marrow function is also important. A complete blood count (CBC) measures your red blood cells, white blood cells, and platelets. If your counts are too low — perhaps because cancer has spread to the bone marrow or because of previous treatments — you may not be eligible for trials involving chemotherapy or other drugs that can further suppress blood cell production.^[8]

Heart function may be tested with an electrocardiogram (EKG) or an echocardiogram (ultrasound of the heart). Some cancer drugs, especially certain targeted therapies, can affect the heart. Doctors need to know your heart is healthy enough to tolerate the treatment being studied.^[8]

Prior Treatment History

Clinical trials often have rules about what treatments you can or cannot have received before enrolling. Some trials are for patients who have already tried several treatments and are looking for new options. Others are for patients who are just starting treatment for metastatic disease. You will need to provide detailed records of your previous treatments, including dates, types of drugs, and how well they worked.^[10]

Sometimes trials require that a certain amount of time has passed since your last treatment before you can join. This “washout period” ensures that any side effects from your previous treatment have resolved and won’t interfere with the study results.^[10]

Performance Status

Researchers also need to know how well you are functioning in your daily life. This is measured using something called performance status. There are different scales, but they generally assess whether you can take care of yourself, do light activities, or need to spend a lot of time in bed. Most clinical trials require that participants are able to care for themselves and be up and about at least part of the day. This ensures that patients are strong enough to tolerate the treatment and complete the study.^[8]

Diagnostic tests and evaluations for clinical trial eligibility can seem overwhelming, but they are designed to protect your safety and ensure the trial produces reliable results. If you are interested in joining a clinical trial, talk to your doctor about what tests you might need and whether you might be a good candidate for any available studies.^[10]